Salius Pharma's Worldwide Growth plan for Chronic Therapy APIs Segment

Creating a Global Impact with Superior Quality APIs for the Management of Chronic illnesses

 

Overview

 

Chronic conditions such as diabetes, cardiovascular disease, hypertension, respiratory disorders, and cancer are steadily increasing across global populations, placing immense pressure on healthcare systems and access to affordable treatment.

 

At Salius Pharma, we are actively expanding our footprint across Latin America, Southeast Asia, Africa, and the CIS region as a reliable manufacturer and exporter of high-quality Active Pharmaceutical Ingredients (APIs).

 

Why Pay Attention to APIs for Chronic Therapy?

 

 The New Global Epidemic Is Chronic Conditions

 

With increasing incidences of chronic conditions like diabetes, cardio- respiratory disease and cancer, there is a growing demand worldwide for effective therapy. This has spurred demand for APIs, especially those used in chronic illness therapies. Over 70% of deaths worldwide are attributed to non-communicable diseases (NCDs), according to the WHO. APIs for treating chronic diseases are in high on demand worldwide due to their increasing prevalence, which presents a significant opportunity for specialty pharmaceutical suppliers.

 

The Strategic Advantage of Salius Pharma

 

• – GMP/WHO-certified manufacturing facilities
• – Prompt regulatory assistance, such as stability data, COAs, and DMF filing.

 

Strong portfolio of chronic care APIs, including:

Therapeutic Area	API Name
Diabetes Management	Metformin HCl
	Glimepiride
	Sitagliptin Hydrochloride
	Pioglitazone HCl
Hypertension	Amlodipine Besylate
	Enalapril
	Lisinopril
	Hydrochlorothiazide
	Ramipril
Hyperlipidaemia	Atorvastatin Calcium
	Ezetimibe
	Rosuvastatin
	Simvastatin
Neuropathic Pain	Mirtazapine
	Risperidone
	Sodium Valproate
	Gabapentin
Cardiovascular	Atorvastatin Calcium
	Losartan Potassium
	Metoprolol Succinate
	Rosuvastatin Calcium
Anti-Cancer	Irinotecan HCl. Trihydrate
	Oxaliplatin
	Tamoxifen

 

Our Global Expansion Plan

 

Target Markets We want to expand globally in the following regions: 

 

Latin America	Africa	Asia	CIS & Eastern Europe
Argentina Brazil Mexico Peru Chile Colombia Bolivia	Tanzania Ethiopia Ghana Nigeria Kenya South Africa	Thailand Malaysia China Vietnam Philippines, Bangladesh Sri Lanka	Uzbekistan Kazakhstan Ukraine Georgia Belarus

 

 

🤝 Partnerships and Licensing

 

• – Formulating partnerships with local manufacturer of generic medications and Bulk drug distributors
• – Customization of bulk quantities of pharma raw materials, regulatory documentation, and technical support
• – Flexible supply chain models to meet local regulatory requirements and pricing

 

Quality Compliance & Innovation

 

At Salius Pharma quality is paramount. All our APIs for chronic therapy segment have:

 

• • – Rigorous QA/QC processes
  • – Consistent in manufacturing from batch-to-batch
  • – Validated testing methods with stringent GLP guidelines
  • – The relevant ICH, WHO GMP and country specific regulations.

We also invest in R&D to develop cost effective method to synthesise APIs that are optimized and less costly.

 

Salius Pharma: Your Reliable & trusted API Partner in Chronic Care Segment

 

 With a growing global network of partners and a large segment of API on pipeline, Salius Pharma is positioned to aid the world in the fight against long-term chronic disease. We are currently expanding not only our reach around the world but also expanding access to chronic care treatment solutions for millions around the globe for quality and most affordable care.

 

Call to Action

 

Are you searching for a trusted API exporter for chronic segments?

 

👉 Contact Salius Pharma today for product catalogues, regulatory documentations and quote

 

📧 Email: export@saliuspharma.com

🌐 Website: https://saliuspharma.com